Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 51 of the 52 references it cites were found in a registry or an index; 3 of the 66 sources its claims cite were checked for support.

ACTH Stimulation Test for the Diagnosis of Secondary Adrenal Insufficiency: Light and Shadow

Open access

Abstract

Secondary Adrenal Insufficiency (SAI) is a condition characterized by inappropriately low ACTH secretion due to a disease or injury to the hypothalamus or the pituitary. The evaluation when suspected is often challenging for the non-specific symptoms, the rarity of the disease, and the pitfalls associated with laboratory tests. A prompt and correct diagnosis of SAI is essential because although an adequate hormonal replacement therapy could be lifesaving, inappropriate life-long therapy with steroids can be harmful. The gold standard test for assessing the hypothalamus-pituitary-adrenal axis (HPA) is the insulin tolerance test (ITT), but due to safety issues is not widely used. Conversely, the ACTH stimulation test is a safer and well-tolerated tool for SAI diagnosis. However, data about its diagnostic accuracy show great variability due to both technical and interpretative aspects, such as dose, route of administration, the timing of the test, and assay used for cortisol measurements. Consequently, the clinical background of the patient and the pretest probability of HPA axis impairment become of paramount importance. We aimed to summarize the recent literature evidence in the conduction and interpretation of the ACTH stimulation test for the diagnosis of SAI to provide updated insights on its correct use in clinical practice.

Overview

CoChat Summary

TL;DR

This narrative review summarizes evidence on the ACTH stimulation test for secondary adrenal insufficiency (SAI), emphasizing that both standard- and low-dose tests are useful but accuracy varies with protocol, timing, and cortisol assay. It highlights assay-specific cortisol cutoffs and the need to select patients by pretest probability, while noting unresolved technical and validation issues.

Key findings

  • The ACTH stimulation test is safer and better tolerated than the insulin tolerance test for SAI, but diagnostic accuracy varies by dose, route, timing, and assay; a patient-level meta-analysis found low-dose ACTH superior to standard-dose ACTH (AUC 0.94 vs. 0.85, p < 0.001).
  • Low-dose preparation is technically problematic: surveyed dilution methods delivered actual doses from 0.16 to 0.81 μg instead of 1 μg, up to seven-fold less; the minimal ACTH dose reported to induce peak cortisol was 0.5 μg cosyntropin.
  • Interpretation depends on assay: the traditional peak cortisol cutoff >18.1 μg/dL (500 nmol/L) excludes AI, but newer specific assays measure cortisol 20–36% lower; suggested 30-min cutoffs are 12.6–14.6 μg/dL with Elecsys Cortisol II and 13.3–14.9 μg/dL with Beckman Access.
  • Guidelines suggest testing 6 weeks after pituitary surgery and ≥18 h after the last hydrocortisone dose, with morning cortisol 3–15 μg/dL as the grey zone for testing; adding a 60-min cortisol to 30-min sampling reclassifies 10–24% of patients from AI to sufficient.

Methods

  • Narrative review using PubMed; search terms included “ACTH stimulation test,” “cosyntropin stimulation test,” or “short Synacthen Test (SST)” combined with “secondary adrenal insufficiency” or “secondary hypoadrenalism,” “pituitary surgery,” “pituitary disease,” or “trans-nasal-sphenoidal surgery.”
  • The authors reviewed English-language papers on the ACTH stimulation test and selected those on adrenal insufficiency secondary to pituitary surgery or pituitary disease.

Limitations

  • Stated: there is no consensus on the most reliable ACTH test protocol; low-dose dilution methods vary and often underdeliver corticotropin; studies proposing new assay-specific cutoffs mostly used standard-dose ACTH, small cohorts, and did not differentiate causes of AI; large prospective validation is needed.
  • Stated: few studies address the appropriate frequency of repeat dynamic testing; data on glucagon and metyrapone tests are limited, with no comparative adult studies of glucagon vs. ACTH and limited pediatric data.
  • Evident: as a narrative review, it does not report a systematic search, risk-of-bias assessment, or quantitative synthesis; conclusions therefore rest on heterogeneous studies and expert interpretation.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/biomedicines11030904

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Summary of the latest evidence on the conduction and interpretation of the ACTH test for the diagnosis of SAI. The range of new cutoffs proposed in the figure are from studies conducted using Elecsys Cortisol generation II assay.
Figure 1 Summary of the latest evidence on the conduction and interpretation of the ACTH test for the diagnosis of SAI. The range of new cutoffs proposed in the figure are from studies conducted using Elecsys Cortisol generation II assay.CC BY · PubMed Central

Verification

Claims the paper makes

3 Valid · 0 Not valid · 45 Not checked · 13 Own results and interpretations

26 more claims

Create a free account to see all 61 claims and to verify the 56 references still open.

See all claims — free account
  • It may state two separate claims as one. 26
  • Probably not a substantial claim. 9

Create a free account to see these claims.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

3 of 3

Citations

Cites

Show all 52 references

Cited by

See all 19

Metadata

Authors
Birtolo, M. F., Antonini, S., Saladino, A., Zampetti, B., Lavezzi, E., Chiodini, I., Mazziotti, G., Lania, A. G. A., & Cozzi, R.
Affiliations
  • Humanitas University (IT)
  • Fondazione IRCCS Istituto Neurologico Carlo Besta (IT)
  • Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda (IT)
  • University of Milan (IT)
Corresponding author
Lania, Andrea G. A.
Venue
Biomedicines
Publisher
MDPI AG
Published
2023-03-15
Volume
11
Issue
3
Pages
904
ISSN
2227-9059 (ISSN-L)
OpenAlex
W4324357303
Cited by
19
References
52
Citations by year
2026: 4 · 2025: 8 · 2024: 4 · 2023: 2
FWCI
0.53
Type
journal article
Language
en
Open access
Locations
  • Biomedicines (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
Keywords
secondary adrenal insufficiency, ACTH stimulation test, hypothalamic-pituitary-adrenal axis, insulin tolerance test, cortisol measurement, diagnostic accuracy, test interpretation, steroid replacement therapy, pituitary disorders, hypothalamic disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-11-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-11-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: ACTH Stimulation Test for the Diagnosis of Secondary Adrenal Insufficiency: Light and Shadow. https://app.cochat.ai/papers/10.3390/biomedicines11030904
The paper
Birtolo, M. F., Antonini, S., Saladino, A., Zampetti, B., Lavezzi, E., Chiodini, I., Mazziotti, G., Lania, A. G. A., & Cozzi, R. (2023). ACTH Stimulation Test for the Diagnosis of Secondary Adrenal Insufficiency: Light and Shadow. Biomedicines. https://doi.org/10.3390/biomedicines11030904

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.